New-Test Feline Health Maker Combo Test Kit (5in1) —Ka hoʻohana ʻana o ka huahana i kahi hihia o Feline Hypertrophic Obstructive Cardiomyopathy (HOCM)
Nā huahana ma ka papa inoa o kēia pilikia:
New-Test Feline Health Markers Combo Test kits (Figure 1, left) (50ul plasma hiki ke ʻike i ka feline pancreatic lipase (fPL), feline glycocholic acid (CG: liver cell damage and bile stasis), fNT-proBNP (cardiac load index) , cystatin C (CysC: glomerular filtration index), huina allergen iGE (macromolecule immune allergy) ma 10 minuke.
1. Ka moʻolelo olakino:
Pōkole ʻAmelika, Wahine, 4 Makahiki.
Moʻolelo lapaʻau: Diaphragmatic Hernia, TMT (Transient Cardiomyopathy)
ʻO ka wehewehe ʻana o ka mea nona:
ʻO ka mea nona ka hale ma waho o ka hale no hoʻokahi pule i ka hoʻomākaukau ʻana i ka meaʻai lawa no ka pōpoki. Aia kekahi ʻōpiopio ʻōpio Golden British Shorthair e noho pū me ia. Hoʻohui maikaʻi ʻia nā pōpoki ʻelua me ke koʻikoʻi ʻole i hōʻike ʻia ma luna o ka pōpoki. Ma hope o ka hoʻi ʻana mai i ka home, ʻike ka mea nona nā hōʻailona o ka pōkole hanu a me ka paʻakikī o ka ʻū.
2. Nā hoʻokolohua Laboratory
①New-Test Health Makers combo Testing Figure 2: ua hōʻike nā hopena i ka maikaʻi o ka NT-proBNP, a ua hui pū ʻia me nā hōʻailona lapaʻau, kahi i manaʻo ʻia ai nā pilikia puʻuwai e like me ka puʻuwai acute (AHF). Ua manaʻo ʻia ʻo FPL (kiʻekiʻe), a pono e hoʻohui i nā hōʻailona he nui a me nā hopena lapaʻau e noʻonoʻo ai he kumu lua. No ka mea ʻaʻole kiʻekiʻe nā hōʻailona, pono e hoʻolohe wale iā lākou i ka wā o ka mālama ʻana. ʻO nā mea hōʻailona ʻē aʻe (ākea, gallbladder, kidney, a me ka allergy) i hoʻāʻo maʻamau ma mua o ka hoʻokipa ʻana. Ua hoʻoholo ʻia ka hoʻolālā diagnostic hou e hui pū me nā hopena o ka hoʻāʻo 5in1: Cardiac ultrasound a me Digital Radiography.
②Ke kiʻi 3-6 o ka naʻau: ʻo nā hopena i manaʻo ʻia ka lakene AO o 1.92 a me ka neʻe ʻana o ka lau mua o ka pahu mitral (Systolic Anterior Motion), hema atrium anawaena o 16 mm, myocardium hypertrophy o ka wahi holoʻokoʻa.
③ Digital Radiography: Ua mānoanoa a pōwehiwehi ke ʻano o ka māmā, ua hoʻonui ʻia ka wai a puni ka pulmonary vascular a me ka bronchus, ua hōʻike ke kiʻi mua i kahi hōʻailona ala ʻelua, a ʻike ʻia ka hōʻailona donut. He ʻano ʻino ke ʻano o ka puʻuwai e hōʻike ana i ka edema pulmonary.
Kiʻi 7 DR ma ka lā mua o ka hale maʻi (pulmonary edema)
Kiʻi 8 Kiʻi o ka hoʻihoʻi ʻana ma hope o ka mālama ʻana i ʻelua lā
Nā hualoaʻa diagnostic 3.Comprehensive
ʻO ka Systolic Anterior Motion (SAM) ， ʻO ka edema pulmonal
4. ʻŌlelo aʻoaʻo lapaʻau (no ka ʻike wale nō):
①Inhalation, diuresis, sedation
②Laau lapaʻau
5. Nā lāʻau lapaʻau maʻamau
Furosemide: 1-4 mg/kg iv, hoʻokahi manawa i kēlā me kēia 2 hola
Pimobendan: 0.25-0.3 mg/kg, hoʻokahi manawa i kēlā me kēia 12 hola, po
Enalapril: 2.5 mg/po, q24h
Atenolol: 6.25 mg / kēlā me kēia, po, q24h
6. ʻO Systolic Anterior Motion (SAM)
Systolic Anterior Motion. Ua ʻōlelo pinepine ʻia i ka wā o ka nānā ʻana i ka ultrasound cardiac a maʻamau i nā kūlana e like mehypertrophic obstructive cardiomyopathy, (HOCM).
Nā hana lapaʻau maʻamau:
Ka mālama lāʻau: Ma o ka hoʻohana ponoʻana i ka lāʻau lapaʻau, e like me nā βblockers (e like me atenolol, a me nā mea'ē aʻe), nā antagonists calcium (e like me ka diltiazem, a me nā mea'ē aʻe), hiki ke hāʻawi i ka mana maikaʻi o ke kūlana. Hiki i kēia mau lāʻau lapaʻau ke hoʻoponopono i ka puʻuwai o ka puʻuwai, hoʻemi i ka contractility o ka myocardium, a hoʻomaikaʻi i ka hana diastolic o ka myocardium, a laila e hoʻopau i nā pilikia pili e like me ka cardiac infarction a me ka myocardial ischemia i hoʻokumu ʻia e ka "SAM", e ʻae ana i ka naʻau e hana maʻalahi. ʻoi aku ka maʻamau, a hoʻemi i ka pinepine o nā hōʻailona lapaʻau e like me dyspnea a me ka syncope i nā pōpoki. Hiki i nā pōpoki he nui ke mālama i ke ola paʻa ma hope o ka lāʻau lapaʻau maʻamau. No ka laʻana, hiki i kekahi mau pōpoki me nā kūlana haʻahaʻa a haʻahaʻa ke hana maʻamau i kēlā me kēia lā ma hope o ka lawe ʻana i ka lāʻau lapaʻau, e like me ka hele kūpono, ʻai a inu, etc.
Hooponopono ola maikai: E like me ka hoʻolako ʻana i kahi noho mālie a me ka ʻoluʻolu, ka pale ʻana i ka makaʻu, ka hoʻoluhi ʻana, a me ka hoʻoikaika ikaika, a me nā hoʻoponopono meaʻai kūpono, ka mālama ʻana i ke kaumaha, a me ka meaʻai kaulike, e kōkua pū i ka mālama ʻana i ke kūlana. Eia kekahi laʻana, hiki i ka pōpoki me ka "SAM" i loko o ke kūlana paʻa ke piʻi aʻe kona mau hōʻailona inā noho ʻo ia i kahi ʻano walaʻau a hahai pinepine ʻia e nā holoholona ʻē aʻe a hoʻoikaika kino; Inā noho ʻo ia i kahi kaiapuni kūpono a loaʻa iā ia ka hoʻokele meaʻai kūpono, hiki ke hoʻomalu ʻia kona kūlana ma ke ʻano paʻa.
Nānā mau: E lawe i kāu pōpoki i ka halemai holoholona no ka nānā mau. Ma o nā hōʻailona o NT-proBNP, ultrasound cardiac, electrocardiogram, a me nā hōʻike kuhikuhi pili koko, hiki iā ʻoe ke hoʻomau i ka nānā ʻana i nā loli o ke kūlana a me ka hana o ka naʻau. Ināʻikeʻoeʻaʻole maikaʻi ka hopena o ka lāʻau lapaʻau a iʻole e holomua ana ke kūlana, hiki iāʻoe ke hoʻololi koke i ka papahana lapaʻau, hoʻololi i keʻano o ka lāʻau lapaʻau a hoʻololi paha i keʻano, a pēlā aku. ʻoi aku ka maikaʻi a me ka lōʻihi o ka mana o "SAM".
He mea e ʻōlelo ai ʻo New-Test Product Manager
ʻO New-Test Feline Health Marker Combo Test Kit kahi huahana i hoʻomohala ʻia e New-Test Biotech i 2022 me ka nui o ka hoʻopukapuka R&D. He huahana waiwai nui ia, i hoʻohana nui ʻia no ka nānā ʻana i ke olakino makahiki o nā pōpoki waena a me nā ʻelemakule. ʻO 50uL wale nō o ka plasma koko hiki ke hoʻohana ʻia no ka ʻike ʻana i ʻelima mau helu lāʻau lapaʻau e pili ana i ke olakino pili i loko o 10 mau minuke e nānā i ke kūlana olakino o ka pancreas, hana renal, ate, gallbladder, naʻau a me nā allergies piha. ʻOi aku ka kikoʻī a me ka maʻalahi o nā ʻōlelo aʻoaʻo ma mua o ka biochemical indexes, no laila he mea koʻikoʻi ka ʻike mua ʻana a me ka mālama ʻana, ʻaʻole wale ia e hōʻemi i ke kaumaha holoʻokoʻa ma luna o nā mea nona nā holoholona, akā, e hoʻomalu pono i ka hoʻololi ʻana o ka maʻi maʻi i ka maʻi koʻikoʻi.
ʻikepili helu
Ma o ka helu helu kumulative o 58,766 mau ho'āʻo kūpono (menā mākaʻikaʻia me ka hōʻoia ʻana o nā mea kūʻai aku) i nā makahiki ʻelua i hala iho nei, ʻo ka helu ʻike o fpl he 16.06%; ʻo ka helu maikaʻi o CG he 21.4%; ʻo ka helu ʻike o fNT-proBNP he 24.25%; ʻo ka helu kūpono o fcysc he 6.06%; ʻo ka helu kūpono o ftIgE he 55.43%; ka helu awelika o nā hihia i ʻike ʻia ekēlā me kēiahoʻokahikaila lehulehu pahu hoʻāʻoʻo ia: 1.14, a ʻo ka nui o nā hihia i ʻike ʻiae kēlā me kēiahoʻokahipahu ho'āʻo kanal lehulehuma hope o ka wehe ʻia ʻana o TIgE he 0.58 (ʻekolu panelaʻike ʻiaʻelua maʻi maʻi maʻi). ʻAʻole hiki i nā holoholona ke kamaʻilio, ʻaʻole lākou e ʻimi i ka lāʻau lapaʻau ke loaʻa ka maʻi, a ʻaʻole hiki iā lākou ke haʻi maikaʻi i ko lākou ʻeha a me ka ʻeha i ko lākou aloha.nā mea nona. Ua ʻōlelo ʻo The ma'i ko'iko'i loa 'o ia i ka wāna mea nonaʻike, a piʻi aʻe ka pilikia o ka lapaʻau ʻana i kēia manawa. Ua ʻōlelo ʻo The haʻahaʻa ke ola o ka lāʻau, a he pipiʻi loa ke kumukūʻai o ka lāʻau. ʻO kaHōʻike HouOla FelineʻO ka pahu hoʻāʻo hui pū ʻo Maker 5in1ua hoʻohana mau ʻia i ka nānā ʻana i nā pōpoki makahiki. ʻO iahiki ke nānā i ka hiki ʻana o nā maʻi maʻamau maʻamau i nā pōpoki ma mua e hoʻokō i ka ʻike mua a me ka mālama mua ʻana, ae hoʻomalu pono i ka maʻi maʻi i kahi kūlana koʻikoʻi. ʻAʻole walemālama i ke olakino o nā holoholona aloha, akā pū kekahie hoemi i ka huina o ka uku lapaau nonā mea mālama holoholona.
Ka manawa hoʻouna: Dec-07-2024
